[Treatment outcome of purulent meningitis in adults from material of the Clinic of Infectious Diseases AM in Lodz in the years 1990-1991]

Pol Tyg Lek. 1994 May;49(20-22):472-4.
[Article in Polish]

Abstract

81 patients (pts) with bacterial meningitis hospitalised in the Clinic for Infectious Diseases in the years 1990-1991 were treated according to two therapeutic schedules. First: young pts (under 40 years), without coexisting diseases obtained Penicillin G and aminoglycoside and/or synthetic penicillin. Second: pts over 40 years old with coexisting diseases or cases of recurrent meningitis were treated with third-generation cephalosporins and aminoglycoside and/or synthetic penicillin. The mortality was 16% in the study group. 11 of 13 pts with coexisting diseases died. Neurologic sequelae were found in 23% of pts. The complete recovery was obtained in 34% of pts, more often (35.9%) in a group treated with third--generation cephalosporins comparing to 29.4% with other antibiotic therapy.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aminoglycosides
  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins / therapeutic use
  • Female
  • Humans
  • Male
  • Meningitis, Bacterial / complications
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / mortality
  • Middle Aged
  • Nervous System Diseases / etiology
  • Penicillins / therapeutic use
  • Recurrence
  • Survival Rate
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins
  • Penicillins